跳至主要内容
临床试验/JPRN-UMIN000025261
JPRN-UMIN000025261招募中未知

Multi-institutional retrospective observational study of effectiveness and safety of treatment with Nivolmab for advanced or recurrent non-small cell lung cancer harboring EGFR mutation. - Multi-institutional retrospective observational study of effectiveness and safety of treatment with Nivolmab for advanced or recurrent non-small cell lung cancer harboring EGFR mutation.

HANSHIN Oncology Group0 个研究点目标入组 100 人开始时间: 2016年12月31日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100